151 related articles for article (PubMed ID: 23677251)
1. Leukemia kidney infiltration can cause secondary polycythemia by activating hypoxia-inducible factor (HIF) pathway.
Osumi T; Awazu M; Fujimura E; Yamazaki F; Hashiguchi A; Shimada H
Eur J Pediatr; 2013 Jun; 172(6):829-32. PubMed ID: 23677251
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin gene expression in renal carcinoma is considerably more frequent than paraneoplastic polycythemia.
Wiesener MS; Münchenhagen P; Gläser M; Sobottka BA; Knaup KX; Jozefowski K; Jürgensen JS; Roigas J; Warnecke C; Gröne HJ; Maxwell PH; Willam C; Eckardt KU
Int J Cancer; 2007 Dec; 121(11):2434-42. PubMed ID: 17640059
[TBL] [Abstract][Full Text] [Related]
3. Paraneoplastic erythrocytosis associated with an inactivating point mutation of the von Hippel-Lindau gene in a renal cell carcinoma.
Wiesener MS; Seyfarth M; Warnecke C; Jürgensen JS; Rosenberger C; Morgan NV; Maher ER; Frei U; Eckardt KU
Blood; 2002 May; 99(10):3562-5. PubMed ID: 11986208
[TBL] [Abstract][Full Text] [Related]
4. Polycythemia Secondary to Renal Hemangioblastoma: A Case Report and Literature Review.
Lee Y; Cheng SM; Hwang DY; Chiu YL; Chou YH
Int J Surg Pathol; 2024 Feb; 32(1):140-144. PubMed ID: 37150964
[TBL] [Abstract][Full Text] [Related]
5. Tumor biology of non-metastatic stages of clear cell renal cell carcinoma; overexpression of stearoyl desaturase-1, EPO/EPO-R system and hypoxia-related proteins.
Stoyanoff TR; Rodríguez JP; Todaro JS; Espada JD; Colavita JP; Brandan NC; Torres AM; Aguirre MV
Tumour Biol; 2016 Oct; 37(10):13581-13593. PubMed ID: 27468719
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin protects the kidneys against ischemia reperfusion injury by activating hypoxia inducible factor-1alpha.
Imamura R; Moriyama T; Isaka Y; Namba Y; Ichimaru N; Takahara S; Okuyama A
Transplantation; 2007 May; 83(10):1371-9. PubMed ID: 17519789
[TBL] [Abstract][Full Text] [Related]
7. Erythrocytosis associated with hyperthyroidism: a rare case report and clinical study of possible mechanism.
Liu X; Liu J; Fan L; Shi B
Endocr Res; 2015; 40(4):177-80. PubMed ID: 25775381
[TBL] [Abstract][Full Text] [Related]
8. Does Renal Tubular Injury-Induced Local Tissue Hypoxia Involve Post-Transplantation Erythrocytosis?
Unal A; Ata S; Karakurkcu C; Ciraci MZ; Kocyigit I; Sipahioglu MH; B Tokgoz ; Oymak O
Transplant Proc; 2017 Oct; 49(8):1930-1934. PubMed ID: 28923650
[TBL] [Abstract][Full Text] [Related]
9. A novel biological function of soluble biglycan: Induction of erythropoietin production and polycythemia.
Frey H; Moreth K; Hsieh LT; Zeng-Brouwers J; Rathkolb B; Fuchs H; Gailus-Durner V; Iozzo RV; de Angelis MH; Schaefer L
Glycoconj J; 2017 Jun; 34(3):393-404. PubMed ID: 27600268
[TBL] [Abstract][Full Text] [Related]
10. MUC1, a new hypoxia inducible factor target gene, is an actor in clear renal cell carcinoma tumor progression.
Aubert S; Fauquette V; Hémon B; Lepoivre R; Briez N; Bernard D; Van Seuningen I; Leroy X; Perrais M
Cancer Res; 2009 Jul; 69(14):5707-15. PubMed ID: 19549898
[TBL] [Abstract][Full Text] [Related]
11. Polycythemia in a Patient With Atonic Bladder and Hydronephrosis.
Katiyar V; Aijaz T; Lingamaneni P; Vohra I; Cisak K
Cureus; 2021 Sep; 13(9):e18094. PubMed ID: 34692308
[TBL] [Abstract][Full Text] [Related]
12. The relationship of erythropoietin overexpression with von Hippel-Lindau tumour suppressor gene mutations between hypoxia-inducible factor-1α and -2α in sporadic clear cell renal carcinoma.
Gong K; Zhang N; Zhang K; Na Y
Int J Mol Med; 2010 Dec; 26(6):907-12. PubMed ID: 21042786
[TBL] [Abstract][Full Text] [Related]
13. Tumor cells are the site of erythropoietin synthesis in human renal cancers associated with polycythemia.
Da Silva JL; Lacombe C; Bruneval P; Casadevall N; Leporrier M; Camilleri JP; Bariety J; Tambourin P; Varet B
Blood; 1990 Feb; 75(3):577-82. PubMed ID: 2297568
[TBL] [Abstract][Full Text] [Related]
14. Regulated oxygen sensing by protein hydroxylation in renal erythropoietin-producing cells.
Wenger RH; Hoogewijs D
Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1287-96. PubMed ID: 20219824
[TBL] [Abstract][Full Text] [Related]
15. Changes in kidney tissue and effects of erythropoietin after acute heart failure.
Güven Bağla A; Içkin Gülen M; Ercan F; Aşgün F; Ercan E; Bakar C
Biotech Histochem; 2018; 93(5):340-353. PubMed ID: 29671622
[TBL] [Abstract][Full Text] [Related]
16. Novel perspectives regarding the physiologic mechanisms by which gliflozins induce reticulocytosis and erythrocytosis.
Heyman SN; Armaly Z; Hamo-Giladi DB; Abassi Z
Am J Physiol Endocrinol Metab; 2023 Nov; 325(5):E621-E623. PubMed ID: 37819195
[TBL] [Abstract][Full Text] [Related]
17. Quantitative RT-PCR assays of hypoxia-inducible factor-1alpha, erythropoietin and vascular endothelial growth factor mRNA transcripts in the kidneys with regard to the cause of death in medicolegal autopsy.
Zhao D; Zhu BL; Ishikawa T; Li DR; Michiue T; Maeda H
Leg Med (Tokyo); 2006 Oct; 8(5):258-63. PubMed ID: 16963303
[TBL] [Abstract][Full Text] [Related]
18. Polycythemic responses to hypoxia: molecular and genetic mechanisms of chronic mountain sickness.
Ou LC; Salceda S; Schuster SJ; Dunnack LM; Brink-Johnsen T; Chen J; Leiter JC
J Appl Physiol (1985); 1998 Apr; 84(4):1242-51. PubMed ID: 9516190
[TBL] [Abstract][Full Text] [Related]
19. Update on mutations in the HIF: EPO pathway and their role in erythrocytosis.
Lappin TR; Lee FS
Blood Rev; 2019 Sep; 37():100590. PubMed ID: 31350093
[TBL] [Abstract][Full Text] [Related]
20. HIF-1α is a protective factor in conditional PHD2-deficient mice suffering from severe HIF-2α-induced excessive erythropoiesis.
Franke K; Kalucka J; Mamlouk S; Singh RP; Muschter A; Weidemann A; Iyengar V; Jahn S; Wieczorek K; Geiger K; Muders M; Sykes AM; Poitz DM; Ripich T; Otto T; Bergmann S; Breier G; Baretton G; Fong GH; Greaves DR; Bornstein S; Chavakis T; Fandrey J; Gassmann M; Wielockx B
Blood; 2013 Feb; 121(8):1436-45. PubMed ID: 23264599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
